A detailed history of Smi Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Smi Advisory Services, LLC holds 1,027 shares of LLY stock, worth $768,206. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,027
Previous 1,012 1.48%
Holding current value
$768,206
Previous $916,000 0.76%
% of portfolio
0.24%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$772.14 - $960.02 $11,582 - $14,400
15 Added 1.48%
1,027 $909,000
Q2 2024

Jul 15, 2024

SELL
$724.87 - $909.04 $3.11 Million - $3.9 Million
-4,288 Reduced 80.91%
1,012 $916,000
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $3.14 Million - $4.2 Million
5,300 New
5,300 $4.12 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Smi Advisory Services, LLC Portfolio

Follow Smi Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smi Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smi Advisory Services, LLC with notifications on news.